Pancreatic Cancer Research

ResearcherKarolinska University HospitalActive in the last 2 years

Helen Kaipe

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7391-1137; OpenAlex author ID A5023468955. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

  1. Exhausted Tumor-infiltrating CD39+CD103+ CD8+ T Cells Unveil Potential for Increased Survival in Human Pancreatic Cancer. Last author DOI 10.1158/2767-9764.crc-23-0405↗
  2. Immunotherapy in pancreatic cancer-an emerging role: a narrative review. First author DOI 10.21037/cco-21-174↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Elena B. Rangelova · 2 shared papers, 2022–2024 · strength 0.54
  2. Carlos Fernández Moro · 1 shared paper, 2024 · strength 0.21
  3. Ebba Asplund · 1 shared paper, 2024 · strength 0.21
  4. Laia Gorchs · 1 shared paper, 2024 · strength 0.21
  5. Ernesto Sparrelid · 1 shared paper, 2024 · strength 0.21
  6. Poya Ghorbani · 1 shared paper, 2024 · strength 0.21
  7. Matthias J. Löhr · 1 shared paper, 2024 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.